A carregar cotações...
Previsão
O preço-alvo médio dos analistas é € 262,19 (-8,71%). A mediana é € 269,77 (-6,07%).
| Comprar |
29 |
| Manter |
13 |
| Vender |
1 |
Notícias Ir para o feed de notícias
Veeva Systems raises annual targets after strong quarter thanks to Vault CRM and AI agents
Veeva Systems beat expectations in the second quarter: revenue rose 18% to $928 million, subscriptions increased 16%, and adjusted earnings per share were $2.35. Management raised the full-year forecast and now expects up to $3.687 billion in revenue and earnings per share of around $9.21. The Vault CRM solution and AI agents were cited as stock drivers, while Veeva continues to expand its market-leading position in the life‑sciences sector. » Mais em finanzen.net
Veeva deepens AI strategy at Citi Global TMT Conference 2026
Veeva emphasized at the conference that about 98% of revenue still comes from the life sciences sector, commercial subscriptions recently showed roughly 13% year‑over‑year growth, and R&D growth has slowed to mid single‑digit to mid‑teens percentages. The newly positioned Falcon platform is intended to automate agent‑based end‑to‑end workflows, complemented by Vault AI for user‑centric productivity features; pricing for AI products will be transaction‑ and usage‑based to preserve software‑like margins. Veeva signals cautious but accelerated AI deployment, opportunistic acquisitions to speed the roadmap, and is launching Aspen as a standalone CRM initiative outside the core sector. » Mais em de.investing.com
Veeva Systems establishes itself as operating system of the pharmaceutical industry with a massive moat
Veeva Systems offers cloud software exclusively for the life‑sciences sector and is used by more than 1,500 pharmaceutical, biotech, and medical‑technology companies for clinical trials, regulatory approval, quality, drug safety, and marketing. Products such as Vault CRM, Development Cloud, Quality Cloud, and Data Cloud are deeply embedded in regulated workflows, creating high switching costs and a strong moat. Veeva is targeting a market share of over 70% and sees AI features as extending this competitive advantage. » Mais em finanzen.net
Dividendos históricos Dividendos
Todos os indicadores de dividendos Todos os indicadoresDados financeiros da empresa
| (EUR) | julho de 2026 | YoY |
|---|---|---|
| Receitas | 804,36 mi | 16,44% |
| Ganho bruto | 603,25 mi | 16,05% |
| Ganho líquido | 237,01 mi | 35,16% |
| EBITDA | 312,4 mi | 29,54% |
Dados fundamentais
| Métrica | Valor |
|---|---|
Capitalização bolsista | € 45,51 bi |
Número de ações | 161,91 mi |
Máximo/mínimo de 52 semanas | € 287,16 - € 132,03 |
| Dividendos | Não |
Beta | 0,93 |
PER (PE Ratio) | 50,76 |
PEG (PEG Ratio) | 2,06 |
P/VC (PB Ratio) | 6,89 |
P/V (PS Ratio) | 14,76 |
Perfil da empresa
Veeva Systems Inc. bietet Cloud-basierte Software für die Life-Sciences-Branche in Nordamerika, Europa, dem asiatisch-pazifischen Raum, dem Nahen Osten, Afrika und Lateinamerika. Das Unternehmen bietet Veeva Commercial Cloud an, eine Suite von Software-, Daten- und Analyselösungen, die Veeva Customer Relationship Management (CRM) und Veeva Medical CRM, Veeva CLM, Veeva CRM MyInsights umfassen, Veeva CLM, Veeva CRM Approved Email, Veeva CRM Engage, Veeva Align, Veeva CRM Events Management, Veeva Nitro, Veeva OpenData, Veeva Link, Veeva Network, Veeva Crossix, Veeva Data Cloud, und MyVeeva for Patients; und Veeva Vault, eine Cloud-basierte Anwendung für das Content- und Datenmanagement in Unternehmen zur Verwaltung kommerzieller Funktionen, einschließlich Vertrieb und Marketing, medizinischer Inhalte und Kommunikation, sowie von Forschungs- und Entwicklungsfunktionen, wie klinische, regulatorische, Qualitäts- und Sicherheitsfunktionen. Darüber hinaus bietet das Unternehmen professionelle und unterstützende Dienstleistungen in den Bereichen Implementierungs- und Bereitstellungsplanung und Projektmanagement, Anforderungsanalyse, Lösungsdesign und -konfiguration, Management der Systemumgebung und Bereitstellungsdienste, Dienstleistungen, die sich auf die Weiterentwicklung oder Umgestaltung von Geschäfts- und Betriebsprozessen im Zusammenhang mit Veeva-Lösungen konzentrieren, technische Beratungsdienste im Zusammenhang mit Datenmigration und Systemintegrationen, Schulungen zu seinen Lösungen und laufende Managed Services, die ausgelagerte Systemadministration umfassen. Das Unternehmen war früher als Verticals onDemand, Inc. bekannt und änderte im April 2009 seinen Namen in Veeva Systems Inc. Veeva Systems Inc. wurde im Jahr 2007 gegründet und hat seinen Hauptsitz in Pleasanton, Kalifornien.
| Nome | Veeva Systems |
| CEO | Peter Gassner |
| Sede | Pleasanton,
ca EUA |
| Site | |
| Setor | Cuidados de saúde |
| Indústria | Tecnologia de saúde |
| Entrada em bolsa | 06/08/2014 |
| Colaboradores | 7.928 |
Análise aprofundada
Símbolos de ticker
| Bolsa | Símbolo |
|---|---|
NYSE | VEEV |
London Stock Exchange | 0LO3.L |
XETRA | VEE.DE |
Frankfurt | VEE.F |
Düsseldorf | VEE.DU |
London | 0LO3.L |
SIX | VEE.SW |
München | VEE.MU |
Wien | VEEV.VI |
Milan | 1VEEV.MI |